BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 17578436)

  • 1. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
    Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
    Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.
    Cocoş R; Schipor S; Nicolae I; Thomescu C; Raicu F
    Arch Dermatol Res; 2012 Jul; 304(5):335-42. PubMed ID: 22159575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
    Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
    Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the 3'UTR of the prostaglandin synthetase-2 (PTGS-2/COX-2) gene in non-melanoma skin cancer after organ transplantation.
    Gomez-Lira M; Tessari G; Mazzola S; Malerba G; Rugiu C; Naldi L; Nacchia F; Valerio F; Anna B; Forni A; Boschiero L; Sandrini S; Faggian G; Girolomoni G; Turco A
    Exp Dermatol; 2011 Dec; 20(12):1025-7. PubMed ID: 21995456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
    Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
    Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
    Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
    Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations.
    Li M; Gao Y; Li C; Liu L; Li K; Gao L; Wang G; Zhang Z; Gao T
    J Dermatol Sci; 2009 Mar; 53(3):176-81. PubMed ID: 19004621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
    Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
    Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma.
    Moons LM; Kuipers EJ; Rygiel AM; Groothuismink AZ; Geldof H; Bode WA; Krishnadath KK; Bergman JJ; van Vliet AH; Siersema PD; Kusters JG
    Am J Gastroenterol; 2007 Nov; 102(11):2373-9. PubMed ID: 17581270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
    Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
    Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population.
    Shi J; Misso NL; Duffy DL; Thompson PJ; Kedda MA
    Clin Exp Allergy; 2004 Nov; 34(11):1714-8. PubMed ID: 15544595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.
    Li F; Ren GS; Li HY; Wang XY; Chen L; Li J
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):302-5. PubMed ID: 19138835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children.
    Chan IH; Tang NL; Leung TF; Ma SL; Zhang YP; Wong GW; Wong CK; Lam CW
    Allergy; 2007 Jul; 62(7):802-9. PubMed ID: 17573729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk.
    Mazzola S; Lira MG; Benedetti MD; Salviati A; Ottaviani S; Malerba G; Ortombina M; Pignatti PF
    Int J Immunogenet; 2007 Apr; 34(2):71-4. PubMed ID: 17373929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia.
    Colaizzo D; Fofi L; Tiscia G; Guglielmi R; Cocomazzi N; Prencipe M; Margaglione M; Toni D
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):93-6. PubMed ID: 16479190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
    Ueda N; Maehara Y; Tajima O; Tabata S; Wakabayashi K; Kono S
    Cancer Sci; 2008 Mar; 99(3):576-81. PubMed ID: 18167131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
    Langsenlehner U; Yazdani-Biuki B; Eder T; Renner W; Wascher TC; Paulweber B; Weitzer W; Samonigg H; Krippl P
    Clin Cancer Res; 2006 Feb; 12(4):1392-4. PubMed ID: 16489098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
    Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
    Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.